Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.
Stocks to Sell
The pandemic hit many real estate stocks hard, and now rising interest rates are looking like another crippling blow to the industry.
These biotech stocks to sell are at a cross roads with their businesses with few growth catalysts ahead amid this turbulent market.
These seven dividend stocks to sell all have a high risk of being yield traps. Although many of them have already tumbled in price, each one could keep dropping. As the risk of a recession keeps climbing, dividend cut risk could become further factored into their valuations.
These are the top consumer stocks to sell before things get worse. These companies are struggling with issues that will take years to fix.
There's no need to rush into LAZR stock right away. Even if you're already bullish that self-driving technology, and in particular lidar technology, is going to become widely-used, the opportunity to buy it at even more favorable price could emerge.
Even before Biden's 'pandemic is over' declaration, NVAX stock struggled due to weak demand for Novavax's Covid-19 shots.
Rumors and speculation surrounding Cassava Sciences incited a buying frenzy in SAVA stock, but this isn't the time to jump on the hype train.
Consider recent meme chatter as little more than speculative noise. Based on the facts, the best move with AVCT stock is to avoid it.
Don't be complacent about a potential black-swan event. A housing market crash would send these three stocks plunging.
Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over.
With more pain ahead for equities, these seven Nasdaq stocks should be the first to be expelled from investors' portfolios.
It seems the EV industry consolidation will happen rapidly over the next 12 months. And I expect dozens of EV stocks to plunge to zero.
Don't even think about wagering your hard-earned capital on a second-act comeback as INTC stock could sink further on PC-market weakness.
While the winter holiday brings good cheer, there’s not much to cheer about regarding these retail-related stocks to sell.
LYFT stock holders now have to worry about a government crackdown on businesses that hire gig workers, plus multiple lawsuits against Lyft.
Over the past few weeks several leading U.S. companies have issued negative earnings pre-announcements, lowered or pulled their forward guidance, implemented cost cuts, and warned of more pain ahead. The reasons for the dire outlooks range from inflationary pressures to supply chain disruptions.
Pretty soon, the present negatives with FUBO stock will again outweigh its potential future positives. As this could cause shares to tank again (and possibly re-test their 52-week low), steering clear of it is your best move.
The timing surrounding some of Palantir's government contracts is uncertain, and the CEO is frustrated - and so are many PLTR stock holders.
Put simply, PYPL stock right now is a situation with limited upside, coupled with potential near-term downside. Until the proposition changes, continue to avoid it.
These seven marijuana stocks to sell have poor fundamentals and are moving lower as the market is struggling to find a direction.